Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia A
November 24, 2015 at 04:19 AM EST
Swedish Orphan Biovitrum AB (OTC: SWTUY) and Biogen (NASDAQ: BIIB) today announced that the European Commission (EC) has approved ...